Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 40.72B P/E 118.99 EPS this Y 11.30% Ern Qtrly Grth 32.00%
Income 1.1B Forward P/E 26.66 EPS next Y 15.40% 50D Avg Chg 1.00%
Sales 9.64B PEG 2.71 EPS past 5Y 11.72% 200D Avg Chg 13.00%
Dividend N/A Price/Book 2.04 EPS next 5Y 11.98% 52W High Chg -5.00%
Recommedations 1.90 Quick Ratio 1.49 Shares Outstanding 493.24M 52W Low Chg 49.00%
Insider Own 0.14% ROA 2.50% Shares Float 493.44M Beta 0.72
Inst Own 66.11% ROE 5.39% Shares Shorted/Prior 2.99M/2.81M Price 82.10
Gross Margin 55.37% Profit Margin 11.44% Avg. Volume 777,345 Target Price 101.48
Oper. Margin 13.10% Earnings Date Nov 12 Volume 669,333 Change -1.86%
About Alcon Inc.

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Alcon Inc. News
11/19/24 Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
11/18/24 Alcon (ALC) is a Top-Ranked Value Stock: Should You Buy?
11/14/24 Alcon Inc (ALC) Q3 2024 Earnings Call Highlights: Record Cash Flow and Strategic Product ...
11/13/24 Alcon Q3 Earnings Top Estimates, Margins Up, Stock Gains in Afterhours
11/12/24 Alcon (ALC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
11/12/24 Alcon Reports Solid Third-Quarter 2024 Results, including Double-Digit Earnings Growth and Record Cash Generation
11/07/24 What Analyst Projections for Key Metrics Reveal About Alcon (ALC) Q3 Earnings
11/07/24 Alcon Debuts Groundbreaking PRECISION7, a One-Week Replacement Contact Lens to Start and End Every Week Fresh
10/30/24 Alcon Inc. (ALC): Among UBS’ Top Tech Based Disruptive Stocks For 2030
10/27/24 Alcon Singapore Elevates Associate Experience with Inspiring Engagement Programs
10/15/24 Alcon Innovations on Display at AAO 2024 Demonstrate Efficiency and Performance
09/24/24 Reasons to Retain Alcon Stock in Your Portfolio for Now
09/20/24 Innovation Aids Alcon Stock's Growth Despite Macroeconomic Troubles
08/27/24 Alcon Inc. (ALC): One of Oppenheimer’s Top Stock Picks For the Next 12 Months
07:11 AM Alcon (ALC) Q2 Earnings Meet Estimates, Revenues Increase Y/Y
03:52 AM Alcon shares drop on earnings miss
08/20/24 Alcon (ALC) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
08/20/24 Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses
08/20/24 Alcon's (ALC) Market Share Gains, New Launches Aid Growth
08/15/24 Countdown to Alcon (ALC) Q2 Earnings: Wall Street Forecasts for Key Metrics
ALC Chatroom

User Image Stocksrunner Posted - 1 week ago

Top Stocks Near Support Levels: $ALC $AMGN $BLMN Poised for Potential Bounce? Insights on strategic entry points for savvy investors. Check it out! https://stocksrunner.com/posts/1373

User Image HaltTradeAlert Posted - 1 week ago

$ALC Halt Time: 11:52:27 Issue Symbol: ALC Reason Code: T1 Last Price: $88.85 Volume: 2.0 M Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

User Image RobnOptns22 Posted - 2 weeks ago

$ALC Call me crazy but I got 110 for mid December

User Image Il_compy Posted - 10/31/24

$STAA When China unleashed economic stimulus in the past, STAAR benefited. Now, we are waiting for a similar story. That’s the most important thing I took away from this earnings call, in my opinion.” $RXST $ALC

User Image Estimize Posted - 10/28/24

Wall St is expecting 2,464 revenue for $ALC Q3 [Reporting 11/12 AMC] http://www.estimize.com/intro/alc?chart=historical&metric_name=revenue

User Image WeeklyTrader Posted - 10/23/24

In the red for $ALC! RSI: 40.75% 50-day MA: $96.65 200-day MA: $87.64

User Image WeeklyTrader Posted - 1 month ago

What’s your vibe on $ALC right now? RSI: 50.33% 50-day MA: $96.21 200-day MA: $87.08

User Image Msylaj Posted - 1 month ago

$ALC please

User Image bravo33 Posted - 1 month ago

$ALC Needs to reestablish 95.90 as floor for further ramp

User Image ChristaBoarts Posted - 1 month ago

$ALC advances healthcare with cutting-edge eye care solutions, improving the quality of life for millions worldwide. Powered by FAAS.

User Image Etrading Posted - 1 month ago

I have huge silver $alc call due to some huge buyers !! Well I am against the $spy $qqq for sure but low CPI coming this week just like last time .. Then $tlt must pump but MM making yield pump instead All opposite of logic .. One way or other this RIGGED market will correct

User Image bravo33 Posted - 1 month ago

$ALC Sideways for a few weeks, remains fundamentally strong

User Image Msylaj Posted - 09/23/24

$ALC I bought this stock this morning!!! Wtf is happening lol

User Image RobnOptns22 Posted - 2 months ago

$ALC Added

User Image bravo33 Posted - 2 months ago

$ALC Added Feb $95 calls

User Image HammerstoneMarkets Posted - 2 months ago

$BLCO +3.71% after y'day's +14% gain following an article on Saturday in the @FT stating that Bausch + Lomb is exploring a sale to separate itself from parent Bausch Health ( $BHC). This morning: -A Jefferies note said a sale would be a big positive for $BHC's (Buy, $9 PT) equity & debt shareholders. On Monday: -Wells Fargo said a sale "makes sense to us given the steep valuation discount between $BLCO (OW, $23 PT) and its closest eye care peers." -JPMorgan disagreed, saying the valuation discount (vs $COO & $ALC) is warranted b/c 70% of $BLCO's (Neutral) earnings emanate from their drug units & not eye care units. - $BHC -shares are +12.6% over the past 2 days

User Image Douglas06 Posted - 2 months ago

@GreedyBunny @KaydeeHet $COO & $ALC average EV of 23x EBITDA. Same valuation for $BLCO And it's worth $20B. Wipes out almost entire $BHC debt

User Image StockInvest_us Posted - 2 months ago

Signal alert: $ALC - PivotPoint bottom https://stockinvest.us/l/o6e6OXeP4z

User Image Dollellama44 Posted - 08/23/24

$ALC 👍👍

User Image Thestocktraderhubzee Posted - 08/22/24

$ALC Wells Fargo Maintains Overweight on Alcon, Raises Price Target to $105

User Image xMonti Posted - 08/22/24

$ALC $COO ✌️

User Image Thestocktraderhubzee Posted - 08/22/24

$ALC Baird Maintains Outperform on Alcon, Raises Price Target to $110

User Image OpenOutcrier Posted - 3 months ago

$ALC (-2.6% pre) Alcon shares drop on earnings miss - inv https://ooc.bz/l/40658

User Image Smartinvestor905 Posted - 3 months ago

$ALC

User Image Dollellama44 Posted - 3 months ago

$ALC ER relatively strong. Should regain traction on volume.

User Image stockleapp Posted - 3 months ago

$ALC earnings: Adj. EPS: $0.74 +7% YoY (Est. $0.73) Revenue: $2.48B +3% YoY (Est. $2.53B) "As we look to the second half of the year, our focus will be on preparing for product launches that will position us well for our next phase of growth in 2025” - David J. Endicott, CEO

User Image Estimize Posted - 3 months ago

$ALC misses the Estimize EPS Consensus by 1c and the Estimize Revenue Consensus by $43.51M. Reports FQ2 earnings of 74c EPS and $2.48B ... http://www.estimize.com/alc/fq2-2024?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image epsguid Posted - 3 months ago

$ALC reported earnings of $0.74, consensus was $0.74, Earnings Whisper was $0.77 via @eWhispers #whispermiss http://eps.sh/d/alc

User Image Il_compy Posted - 3 months ago

look at the result of $ALC and see how much market $STAA has captured

User Image Stock_Titan Posted - 3 months ago

$ALC Alcon Reports Second-Quarter 2024 Results with Strong Growth in Implantables and Contact Lenses https://www.stocktitan.net/news/ALC/alcon-reports-second-quarter-2024-results-with-strong-growth-in-n6a0kzf9ve43.html

Analyst Ratings
BTIG Buy Sep 12, 24
RBC Capital Outperform Sep 10, 24
Wells Fargo Overweight Aug 22, 24
Oppenheimer Outperform Aug 22, 24
BTIG Buy Aug 22, 24
Baird Outperform Aug 22, 24
Needham Buy Aug 22, 24
Needham Buy Aug 21, 24
Needham Buy Aug 14, 24